Denosumab/risedronic acid/zoledronic acidOsteonecrosis of jaw: 28 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1791卷 / 1期

关键词：

D O I：

10.1007/s40278-020-74938-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：93 / 93

相关论文

共 50 条

[1] Alendronic acid/risedronic acid/zoledronic acidOsteonecrosis of the jaw: 2 case reports
Reactions Weekly, 2011, 1378 (1) : 5 - 5
[2] Denosumab/zoledronic acidOsteonecrosis of jaw: 3 case reports
Reactions Weekly, 2017, 1676 (1) : 113 - 113
[3] Denosumab/zoledronic acidOsteonecrosis of the jaw: 2 case reports
Reactions Weekly, 2018, 1705 (1) : 117 - 117
[4] Denosumab/zoledronic acidOsteonecrosis of the jaw: 2 case reports
Reactions Weekly, 2021, 1874 (1) : 94 - 94
[5] Denosumab/zoledronic acidOsteonecrosis of the jaw: 2 case reports
Reactions Weekly, 2018, 1719 (1) : 85 - 85
[6] Denosumab/zoledronic acidOsteonecrosis of jaw: 2 case reports
Reactions Weekly, 2019, 1748 (1) : 173 - 173
[7] Adalimumab/risedronic acid/zoledronic acidOsteonecrosis of the jaw: case report
Reactions Weekly, 2014, 1488 (1) : 6 - 6
[8] Denosumab/zoledronic-acidOsteonecrosis of jaw: 2 case reports
Reactions Weekly, 2023, 1974 (1) : 129 - 129
[9] Risedronic-acid/zoledronic-acidOsteonecrosis of the jaw: case report
Reactions Weekly, 2021, 1872 (1) : 439 - 439
[10] Alendronic acid/risedronic acid/zoledronic acidOsteonecrosis: 2 case reports
Reactions Weekly, 2014, 1504 (1) : 5 - 5

← 1 2 3 4 5 →